Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Current Portion of Long-Term Debt
Yield10 Bioscience Inc
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Current Portion of Long-Term Debt
$984k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Current Portion of Long-Term Debt
$7.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
35%
|
CAGR 10-Years
82%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Current Portion of Long-Term Debt
$4B
|
CAGR 3-Years
37%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
984k
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Current Portion of Long-Term Debt amounts to 984k USD.